Product Information
LANSOPRAZOLE DR 30 MG ODT is a generic product labeled by Aurobindo Pharma Limited, priced at $2.1807 per EA under NDC 65862089678. Its NADAC has been published 133 times since Dec 13, 2023.
The High Outlier badge above means this manufacturer's average price in the Lansoprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862089678
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207167On Market Since
3/28/2023
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG ODT has been published 133 times since Dec 13, 2023, and over the history we have for it it has declined 53.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1807 per EA |
|---|---|
| All-time high | $4.6410 (Dec 13, 2023) |
| All-time low | $1.8384 (Apr 22, 2026) |
| 52-week high | $3.1027 |
| 52-week low | $1.8384 |
| Median price | $2.4822 |
| Average price | $2.6104 |
| Largest weekly change | -27.1% (Jan 17, 2024) |
| Weeks tracked | 133 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG ODT, manufactured by Aurobindo Pharma Limited, is $2.1807 per EA (NDC 65862089678), effective Jun 24, 2026.
How has the price of LANSOPRAZOLE DR 30 MG ODT changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG ODT has declined 53.0%. It has been tracked across 133 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG ODT?
Since Dec 13, 2023, the NADAC for LANSOPRAZOLE DR 30 MG ODT has ranged from a low of $1.8384 (Apr 22, 2026) to a high of $4.6410 (Dec 13, 2023), with a median of $2.4822 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG ODT?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LANSOPRAZOLE DR 30 MG CAPSULE, is $0.1067 per EA — about 95% below LANSOPRAZOLE DR 30 MG ODT.
Who manufactures LANSOPRAZOLE DR 30 MG ODT?
LANSOPRAZOLE DR 30 MG ODT (NDC 65862089678) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification